Hovione FarmaCiencia SA Sustainability Profile
Hovione FarmaCiencia SA, commonly known as Hovione, is a prominent player in the pharmaceutical industry, headquartered in Portugal (PT). Established in 1959, the company has evolved into a global leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and drug products, with significant operations across Europe, the United States, and Asia. Hovione is renowned for its expertise in spray drying, particle engineering, and formulation development, offering unique solutions that enhance drug delivery and bioavailability. The company has achieved notable milestones, including successful collaborations with major pharmaceutical firms, solidifying its market position as a trusted partner in the life sciences sector. With a commitment to innovation and quality, Hovione continues to drive advancements in pharmaceutical manufacturing, making it a key contributor to the global healthcare landscape.
DitchCarbon Score
How does Hovione FarmaCiencia SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hovione FarmaCiencia SA's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hovione FarmaCiencia SA's reported carbon emissions
Hovione FarmaCiencia SA, headquartered in Portugal, currently does not report specific carbon emissions data for the most recent year. However, the company is committed to climate action, having established near-term targets as part of its sustainability initiatives. As a current subsidiary of Hovione FarmaCiencia SA, the company is engaged in the pharmaceuticals, biotechnology, and life sciences sector. While it has not set a net-zero target, it is actively working towards reducing its carbon footprint. The company’s near-term target status is marked as "Committed," indicating a proactive approach to addressing climate change. Hovione's climate commitments are part of a broader industry context where pharmaceutical companies are increasingly recognising the importance of sustainability. The absence of specific emissions data does not detract from their commitment to reducing environmental impact, as they align with industry standards and practices. Overall, while specific emissions figures are not available, Hovione FarmaCiencia SA demonstrates a commitment to climate action through its near-term targets and initiatives aimed at reducing carbon emissions in the future.
How Carbon Intensive is Hovione FarmaCiencia SA's Industry?
How Carbon Intensive is Hovione FarmaCiencia SA's Location?
Hovione FarmaCiencia SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hovione FarmaCiencia SA has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
